| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-18 15:12 Tx date 2026-07-28 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Stolick, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
129,000 | ||
| Filed 2026-09-18 15:11 Tx date 2026-01-30 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Gabbai, Eyal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
129,200 | ||
| Filed 2026-09-18 15:09 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
220,320 | |
| Filed 2026-09-18 15:07 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
1,381,200 | |
| Filed 2023-05-09 18:10 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+91,120 vol |
||
| Filed 2023-05-09 18:06 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
| Filed 2026-09-15 22:20 Tx date 2025-04-19 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+25,000 vol |
||
| Filed 2026-09-15 22:16 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Orgil, Oded
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2026-09-15 22:12 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$142,000
+200,000 vol $0.71 each |
550,000 | |
| Filed 2026-09-15 22:11 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,980,000 | ||
| Filed 2026-09-15 22:08 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$71,000
+100,000 vol $0.71 each |
450,000 | |
| Filed 2026-09-15 22:07 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,150,000 | ||
| Filed 2026-09-15 22:06 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$71,000
+100,000 vol $0.71 each |
450,000 | |
| Filed 2026-09-15 22:02 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,150,000 | ||
| Filed 2025-12-03 16:15 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$177,500
+250,000 vol $0.71 each |
||
| Filed 2025-12-03 16:14 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
||
| Filed 2025-12-03 16:11 Tx date 2025-11-27 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
||
| Filed 2025-12-03 15:42 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Drucker, Yoram
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$177,500
+250,000 vol $0.71 each |
||
| Filed 2025-12-03 15:40 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |
||
| Filed 2025-12-03 15:38 Tx date 2025-11-26 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Shaltiel, Lior
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$106,500
+150,000 vol $0.71 each |